Patents by Inventor Allison Mann

Allison Mann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100081723
    Abstract: The present invention provides a method for the treatment of individuals diagnosed with a childhood behavioral disorder such as autistic spectrum disorders or combined type Attention-Deficit/Hyperactivity Disorder (ADHD) by administering an effective amount of memantine.
    Type: Application
    Filed: October 30, 2009
    Publication date: April 1, 2010
    Applicant: FOREST LABORATORIES HOLDINGS LIMITED
    Inventors: Jeffrey Jonas, Pradeep K. Banerjee, Sandeep Gupta, Allison Mann, Hans-Joerg Moebius
  • Publication number: 20090081259
    Abstract: The present invention relates to the treatment of individuals diagnosed with multiple sclerosis, emotional lability or pseudobulbar affect comprising administering to said individual an effective amount of a 1-aminocyclohexane derivative, namely memantine or neramexane.
    Type: Application
    Filed: August 5, 2008
    Publication date: March 26, 2009
    Applicant: MERZ PHARMA GMBH & CO. KGAA
    Inventors: Jeffrey Jonas, Allison Mann, Christopher Graham Raphael Parsons, Wojciech Danysz
  • Publication number: 20060205822
    Abstract: The present invention relates to the treatment of individuals diagnosed with multiple sclerosis, emotional lability or pseudobulbar affect comprising administering to said individual an effective amount of a 1-aminocyclohexane derivative, namely memantine or neramexane.
    Type: Application
    Filed: December 21, 2005
    Publication date: September 14, 2006
    Applicant: Forest Laboratories, Inc.
    Inventors: Jeffrey Jonas, Allison Mann
  • Publication number: 20060079582
    Abstract: The present invention provides a method for the treatment of individuals diagnosed with a childhood behavioral disorder such as autistic spectrum disorders or combined type Attention-Deficit/Hyperactivity Disorder (ADHD) by administering an effective amount of memantine.
    Type: Application
    Filed: September 23, 2005
    Publication date: April 13, 2006
    Inventors: Jeffrey Jonas, Pradeep Banerjee, Sandeep Gupta, Allison Mann, Hans-Joerg Moebius